Insulin resistance as a predictor for restenosis after coronary stenting

International Journal of Cardiology

Volumn 103, Issue 2, 2005, Pages 128-134

  Nishio, Kazuaki ^a,b   Fukui, Tomoyasu ^a   Tsunoda, Fumiyoshi ^a   Kawamura, Kitaro ^a   Itoh, Seiji ^a   Konno, Noburu ^a   Ozawa, Kou ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Coronary stent; HOMA IR; In stent restenosis; Insulin resistance; Predictor

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; CHI SQUARE DISTRIBUTION; CONFIDENCE INTERVAL; CORONARY STENT; DIABETES MELLITUS; FEMALE; HEMOGLOBIN DETERMINATION; HOMEOSTASIS; HUMAN; IN-STENT RESTENOSIS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY RESTENOSIS; CORONARY STENOSIS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 23244433942     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.08.039     Document Type: Article

References (35)

1. U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, and L. Kappenberger Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty N. Engl. J. Med. 316 1987 701 706
2. B.S. George, W.D. Voorhees III, and G.S. Roubin Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes J. Am. Coll. Cardiol. 22 1993 135 143
3. A. Schomig, A. Kastrati, and H. Mudra Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure Circulation 90 1994 2716 2724
4. D.L. Fischman, M.B. Leon, and D.S. Baim A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease N. Engl. J. Med. 331 1994 496 501
5. J.P. Carrozza Jr., R.E. Kuntz, R.F. Fishman, and D.S. Baim Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus Ann. Intern. Med. 118 1993 344 349
6. B.D. Klugherz, D.L. DeAngelo, B.K. Kim, H.C. Herrmann, J.W. Hirshfeld, and D.M. Kolansky Three-year clinical follow up after Palmaz-Schatz stenting J. Am. Coll. Cardiol. 27 1996 1185 1191
7. A. Kastrati, A. Schomig, and S. Elezi Predictive factors of restenosis after coronary stent placement J. Am. Coll. Cardiol. 30 1997 1428 1436
8. K.W. Law, Z.P. Ding, A. Johan, and Y.L. Lim Midterm angiographic outcome of single vessel intracoronary stent placement in diabetic versus nondiabetic patients: a matched comparative study Am. Heart J. 136 1998 150 155
9. A. Farb, G. Sangiorgi, A.J. Carter, and V.M. Walley Pathology of acute and chronic coronary stenting in human Circulation 99 1999 44 52
10. R. Komatsu, M. Ueda, T. Naruko, A. Kojima, and A.E. Becker Neointimal tissue response at site of coronary stenting in human: macroscopic, histological and immunohistological analysis Circulation 98 1998 224 233
11. R. Hoffmann, G.S. Mintz, and G.R. Dussaillant Patterns and mechanism of in-stent restenosis. A serial intravascular ultrasound study Circulation 94 1996 1247 1254
12. J.P. Despres, B. Lamarche, and P. Mauriege Hyperinsulinemia as an independent risk factor for ischemic heart disease N. Engl. J. Med. 334 1996 952 957
13. B. Pfefile, and H. Dischuneit Effect of insulin on growth factors of cultured human atrial smooth muscle cells Diabetologia 20 1981 155 158
14. R.W. Stout, E.L. Bierman, and R. Ross Effect of insulin on the proliferation of cultured primate arterial smooth muscle cell Circulation 36 1975 319 327
15. G.M. Reaven Banting lecture 188: role of insulin resistance in human disease Diabetes 37 1988 1595 1607
16. R.A. DeFronzo, and E. Ferrannini Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 1991 173 194
17. N.M. Kaplan The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension Arch. Intern. Med. 149 1989 1514 1520
18. W.T. Friedwald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1978 499 502
19. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 1985 412 419
20. Clinical Alert From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bypass Over Angioplasty for Patients With Diabetes. September 21, 1995.
21. T. Takagi, K. Yoshida, and T. Akasaka Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients J. Am. Coll. Cardiol. 36 2000 731 738
22. R.E. Kuntz, R.D. Safian, J.P. Carrozza, R.F. Fishman, M. Mansour, and D.S. Baim The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting Circulation 86 1992 1827 1835
23. R. Bach, F. Jung, and I. Kohsiek Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty Thromb. Res. 74 Suppl. 1 1994 S55 S67
24. Y. Asakura, M. Suzuki, and H. Nonogi Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM) J. Cardiovasc. Risk 5 1998 331 334
25. J.P. Carrozza, R.E. Kunts, R.F. Fishman, and D.S. Baim Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus Ann. Intern. Med. 118 1993 344 349
26. R. Kornowski, G.S. Mintz, and K.M. Kent Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study Circulation 95 1997 1366 1369
27. S. Elezi, A. Kastrati, and J. Pache Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement J. Am. Coll. Cardiol. 32 1998 1866 1873
28. G.J. Reis, R.E. Kunts, D.I. Silverman, and R.C. Pasternak Effects of serum lipid levels on restenosis after coronary angioplasty Am. J. Cardiol. 68 1991 1431 1435
29. P.K. Shah, and J. Amin Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty Circulation 85 1992 1279 1285
30. D.H. Walter, S. Fichtlscherer, and M.B. Britten Statin therapy inflammation and recurrent coronary events in patients following coronary stent implantation J. Am. Coll. Cardiol. 38 2001 2006 2012
31. R.F. Bonner, G. Keren, P.C. Douek, and M.B. Leon Acute and chronic compression of rigid slotted stents accounts for progressive lumen narrowing Circulation 84 Suppl. II 1991 3098 3102
32. G. Keren, A.D. Pichard, K.M. Kent, L.F. Salter, and M.B. Leon Failure or success of complex catheter-based interventional procedures assessed by intravascular ultrasound Am. Heart J. 123 1992 200 208
33. P.C. Gordon, C.M. Gibson, D.J. Cohen, J.P. Carrozza, R.E. Kuntz, and D.S. Baim Mechanisms of restenosis and redilation within coronary stents quantitative angiographic assessment J. Am. Coll. Cardiol. 21 1993 1166 1174
34. J.A. Painter, G.S. Mintz, and S.C. Wong Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil Am. J. Cardiol. 75 1995 398 400
35. P. Piatti, C. Di Mario, and L.D. Monti Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting Circulation 108 2003 2074 2081